tirzepatide approval canada FDA Grants a New Indication for Obesity Management tirzepatide health canada approval Health

In addition, the triglyceride level increased by 0.4 mmol l 1 during weight loss maintenance in the control group in contrast to the GLP-1RA group where the level remained stable after weight loss, perhaps explained by a GLP-1-induced reduction of the secretion of intestinal triglycerides

Now, before we go any further, we dont have this long-term data yet for people with diabetes

As with any treatment, however, there can be potential side effects to consider

With these drugs, there are physiological changes in peoples bodies that change their desire for food, said Jonathan Bonnet, MD, a lifestyle medicine specialist at Stanford Medicine